-
Je něco špatně v tomto záznamu ?
Cell-free fetal DNA in maternal plasma during physiological single male pregnancies: methodology issues and kinetics
A. Hořínek, M. Korabečná, A. Panczak, Z. Ulčová-Gallová, K. Nouzová, P. Calda, M. Hančárová
Jazyk angličtina Země Švýcarsko
Typ dokumentu srovnávací studie, hodnotící studie
NLK
Karger Journals
od 1998-01-01 do 2009
ProQuest Central
od 1998-01-01 do 2015-12-31
Health & Medicine (ProQuest)
od 1998-01-01 do 2015-12-31
PubMed
18504375
DOI
10.1159/000132400
Knihovny.cz E-zdroje
- MeSH
- biochemická analýza krve metody MeSH
- biologické markery krev MeSH
- DNA krev MeSH
- druhý trimestr těhotenství krev MeSH
- financování organizované MeSH
- kinetika MeSH
- lidé MeSH
- maternofetální výměna látek MeSH
- plod MeSH
- první trimestr těhotenství krev MeSH
- těhotenství krev MeSH
- třetí trimestr těhotenství krev MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- těhotenství krev MeSH
- ženské pohlaví MeSH
- Publikační typ
- hodnotící studie MeSH
- srovnávací studie MeSH
OBJECTIVE: To analyze methodological influences and characterize the concentrations of cell-free fetal DNA (cffDNA) circulating in maternal plasma at different gestational ages in physiological pregnancies. METHODS: We investigated 238 independent samples from single male-bearing pregnancies of different gestation age. In the other 50 pregnancies, the samples were collected three times during pregnancy (at all trimesters) to evaluate the kinetics of cffDNA. The manual and automated DNA extraction methods (Roche) were compared. cffDNA was amplified using real-time PCR method and Y-specific sequences SRY and DYS14. Total cell-free DNA circulating in maternal plasma was determined by the use of the GADPH sequence. RESULTS: The elevation in the concentration of cffDNA during pregnancy with the highest value in the third trimester was observed independently on the DNA extraction method and on the Y-specific amplified sequence. The same is documented for the percentage of fetal DNA in total cell-free DNA in maternal plasma. It increases also in successive trimesters (8.3, 10.7 and 23.2%). CONCLUSIONS: We discuss methodological problems and describe statistical parameters of cffDNA concentrations in maternal plasma during pregnancy as the basic information for comparison with pregnancies having a pathological outcome. Copyright 2008 S. Karger AG, Basel
Citace poskytuje Crossref.org
- 000
- 01758naa 2200433 a 4500
- 001
- bmc11003773
- 003
- CZ-PrNML
- 005
- 20121130120126.0
- 008
- 110302s2008 sz e eng||
- 009
- AR
- 024 __
- $a 10.1159/000132400 $2 doi
- 035 __
- $a (PubMed)18504375
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Hořínek, Aleš, $d 1961- $7 xx0061416
- 245 10
- $a Cell-free fetal DNA in maternal plasma during physiological single male pregnancies: methodology issues and kinetics / $c A. Hořínek, M. Korabečná, A. Panczak, Z. Ulčová-Gallová, K. Nouzová, P. Calda, M. Hančárová
- 314 __
- $a 3rd Medical Department, Charles University, Pilsen, Czech Republic.
- 520 9_
- $a OBJECTIVE: To analyze methodological influences and characterize the concentrations of cell-free fetal DNA (cffDNA) circulating in maternal plasma at different gestational ages in physiological pregnancies. METHODS: We investigated 238 independent samples from single male-bearing pregnancies of different gestation age. In the other 50 pregnancies, the samples were collected three times during pregnancy (at all trimesters) to evaluate the kinetics of cffDNA. The manual and automated DNA extraction methods (Roche) were compared. cffDNA was amplified using real-time PCR method and Y-specific sequences SRY and DYS14. Total cell-free DNA circulating in maternal plasma was determined by the use of the GADPH sequence. RESULTS: The elevation in the concentration of cffDNA during pregnancy with the highest value in the third trimester was observed independently on the DNA extraction method and on the Y-specific amplified sequence. The same is documented for the percentage of fetal DNA in total cell-free DNA in maternal plasma. It increases also in successive trimesters (8.3, 10.7 and 23.2%). CONCLUSIONS: We discuss methodological problems and describe statistical parameters of cffDNA concentrations in maternal plasma during pregnancy as the basic information for comparison with pregnancies having a pathological outcome. Copyright 2008 S. Karger AG, Basel
- 650 _2
- $a biologické markery $x krev $7 D015415
- 650 _2
- $a biochemická analýza krve $x metody $7 D001774
- 650 _2
- $a DNA $x krev $7 D004247
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a plod $7 D005333
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a kinetika $7 D007700
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a maternofetální výměna látek $7 D008431
- 650 _2
- $a těhotenství $x krev $7 D011247
- 650 _2
- $a první trimestr těhotenství $x krev $7 D011261
- 650 _2
- $a druhý trimestr těhotenství $x krev $7 D011262
- 650 _2
- $a třetí trimestr těhotenství $x krev $7 D011263
- 650 _2
- $a financování organizované $7 D005381
- 655 _2
- $a srovnávací studie $7 D003160
- 655 _2
- $a hodnotící studie $7 D023362
- 700 1_
- $a Korabečná, Marie, $d 1961- $7 xx0070811
- 700 1_
- $a Panczak, Aleš. $7 ja20020046920
- 700 1_
- $a Ulčová-Gallová, Zdenka, $d 1954- $7 jn20000402453
- 700 1_
- $a Nouzová, Kamila $7 xx0079583
- 700 1_
- $a Calda, Pavel, $d 1957- $7 mzk2006323882
- 700 1_
- $a Hančárová, Miroslava. $7 xx0275406
- 773 0_
- $t Fetal Diagnosis & Therapy $g Roč. 24, č. 1 (2008), s. 15-21 $w MED00001797
- 910 __
- $a ABA008 $b x $y 7
- 990 __
- $a 20110413121953 $b ABA008
- 991 __
- $a 20121130120155 $b ABA008
- 999 __
- $a ok $b bmc $g 831142 $s 695796
- BAS __
- $a 3
- BMC __
- $a 2008 $b 24 $c 1 $d 15-21 $m Fetal diagnosis and therapy $n Fetal Diagn Ther $x MED00001797
- LZP __
- $a 2011-3B/vtme